VC Deals Analysis: LabCorp Puts Money On January's Biggest Round
Executive Summary
2017 has not got off to a bullish start, with January’s total venture financing deal value barely making it half way past last year’s level. The biggest round, at $40m, went to preterm birth risk specialist Sera Prognostics, catching the eye of the largest lab services provider in the US, LabCorp.
You may also be interested in...
Atlas Genetics Fundraising Pulls In New Chinese Investment
Atlas Genetics, a UK point-of-care molecular diagnostics developer, has raised $35m in Series D financing from an investor syndicate. The funding round attracted existing shareholders and new investment from Chinese in vitro diagnostic company Wondfo Biotech.
VC DEALS ANALYSIS: 2016 Bucks January Trend With Flying Start
January is traditionally a slow month for venture funding deals but 2016 is already distinguishing itself from the previous years with total deal value exceeding well above $600m in the first month.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.